Tania J. Curcio

436 total citations
16 papers, 323 citations indexed

About

Tania J. Curcio is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Tania J. Curcio has authored 16 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 11 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Tania J. Curcio's work include Acute Myeloid Leukemia Research (13 papers), Retinoids in leukemia and cellular processes (4 papers) and Neutropenia and Cancer Infections (3 papers). Tania J. Curcio is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Retinoids in leukemia and cellular processes (4 papers) and Neutropenia and Cancer Infections (3 papers). Tania J. Curcio collaborates with scholars based in United States and Australia. Tania J. Curcio's co-authors include Gail J. Roboz, Eric J. Feldman, Ellen K. Ritchie, Michael S. Samuel, Rebecca F. Carlin, Cindy Ippoliti, Joseph M. Scandura, Fabienne Brenet, Sebastian Mayer and Paul Kligfield and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Tania J. Curcio

16 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tania J. Curcio United States 8 195 187 81 41 41 16 323
P. Flynn United States 6 178 0.9× 135 0.7× 82 1.0× 56 1.4× 74 1.8× 12 320
Tadasu Tobita Japan 10 213 1.1× 206 1.1× 77 1.0× 61 1.5× 42 1.0× 12 381
Daigo Akahane Japan 10 85 0.4× 139 0.7× 63 0.8× 18 0.4× 26 0.6× 46 277
Gioia Colafigli Italy 11 99 0.5× 270 1.4× 54 0.7× 30 0.7× 17 0.4× 41 333
Kiyoshi Okazuka Japan 11 160 0.8× 180 1.0× 108 1.3× 21 0.5× 87 2.1× 36 340
Yaozhong Zhao China 10 152 0.8× 219 1.2× 146 1.8× 25 0.6× 26 0.6× 20 314
MR Motta Italy 7 116 0.6× 306 1.6× 101 1.2× 32 0.8× 76 1.9× 9 356
Ryosuke Ogawa Japan 8 102 0.5× 119 0.6× 50 0.6× 32 0.8× 63 1.5× 37 276
Cinnie Yentia Soekojo Singapore 10 202 1.0× 176 0.9× 110 1.4× 9 0.2× 43 1.0× 30 298
Gaku Oshikawa Japan 10 152 0.8× 169 0.9× 82 1.0× 23 0.6× 26 0.6× 29 326

Countries citing papers authored by Tania J. Curcio

Since Specialization
Citations

This map shows the geographic impact of Tania J. Curcio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tania J. Curcio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tania J. Curcio more than expected).

Fields of papers citing papers by Tania J. Curcio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tania J. Curcio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tania J. Curcio. The network helps show where Tania J. Curcio may publish in the future.

Co-authorship network of co-authors of Tania J. Curcio

This figure shows the co-authorship network connecting the top 25 collaborators of Tania J. Curcio. A scholar is included among the top collaborators of Tania J. Curcio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tania J. Curcio. Tania J. Curcio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ritchie, Ellen K., et al.. (2019). CPX-351 As First Intensive Therapy for Elderly Patients with AML. Blood. 134(Supplement_1). 3858–3858. 5 indexed citations
2.
Lee, Sang‐Min, Ellen K. Ritchie, Caroline Andy, et al.. (2019). Changes in Gut Microbial Diversity and Correlations with Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Receiving Intensive Chemotherapy. Blood. 134(Supplement_1). 1336–1336. 5 indexed citations
3.
Smith, B. Douglas, Andrew W. Roberts, Gail J. Roboz, et al.. (2015). Minimal Residual Disease (MRD) As Exploratory Endpoint in a Phase 1 Study of the Anti-CD123 Mab CSL362 Given As Post-Remission Therapy in Adult Acute Myeloid Leukemia (AML). Blood. 126(23). 3819–3819. 9 indexed citations
4.
Ritchie, Ellen K., Molly D. Greenberg, Tania J. Curcio, et al.. (2014). Comprehensive Geriatric Assessment Does Not Predict Overall Survival in Older Patients with Acute Myeloid Leukemia (AML). Blood. 124(21). 3689–3689. 1 indexed citations
5.
Smith, B. Douglas, Gail J. Roboz, Roland B. Walter, et al.. (2014). First-in Man, Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia (AML) in CR at High Risk for Early Relapse. Blood. 124(21). 120–120. 52 indexed citations
6.
Roboz, Gail J., Ellen K. Ritchie, Rebecca F. Carlin, et al.. (2014). Prevalence, Management, and Clinical Consequences of QT Interval Prolongation During Treatment With Arsenic Trioxide. Journal of Clinical Oncology. 32(33). 3723–3728. 60 indexed citations
7.
Scandura, Joseph M., Gail J. Roboz, Michelle Moh, et al.. (2011). Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML. Blood. 118(6). 1472–1480. 89 indexed citations
8.
Roboz, Gail J., Ellen K. Ritchie, Tania J. Curcio, et al.. (2010). Arsenic trioxide and low-dose cytarabine for patients with intermediate-2 and high-risk myelodysplastic syndrome. Leukemia Research. 35(4). 522–525. 7 indexed citations
9.
Ritchie, Ellen K., Gail J. Roboz, Kenneth W. Hinchcliff, et al.. (2009). Phase I trial of laromustine in combination with infusional ara-C in elderly patients over age 60 with newly diagnosed AML or high-grade MDS. Journal of Clinical Oncology. 27(15_suppl). 7054–7054. 1 indexed citations
10.
Feldman, Eric J., Jeffrey E. Lancet, Jonathan E. Kolitz, et al.. (2008). Phase I Study of a Liposomal Carrier (CPX-351) Containing a Synergistic, Fixed Molar Ratio of Cytarabine (Ara-C) and Daunorubicin (DNR) in Advanced Leukemias. Blood. 112(11). 2984–2984. 6 indexed citations
11.
Roboz, Gail J., Ellen K. Ritchie, Tania J. Curcio, et al.. (2008). Arsenic trioxide and low‐dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia. Cancer. 113(9). 2504–2511. 41 indexed citations
12.
13.
Roboz, Gail J., Francis J. Giles, Ellen K. Ritchie, et al.. (2006). Phase I/II Study of Continuous-Infusion Troxacitabine in Refractory Acute Myeloid Leukemia. Journal of Clinical Oncology. 25(1). 10–15. 13 indexed citations
14.
15.
16.
Feldman, Eric J., Francis J. Giles, Karen Yee, et al.. (2005). A phase 2 clinical trial of AP23573, an mTOR inhibitor, in patients with relapsed or refractory hematologic malignancies. Journal of Clinical Oncology. 23(16_suppl). 6631–6631. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Flynn Breakdown of academic impact, for papers by Tadasu Tobita Breakdown of academic impact, for papers by Daigo Akahane Breakdown of academic impact, for papers by Gioia Colafigli Breakdown of academic impact, for papers by Kiyoshi Okazuka Breakdown of academic impact, for papers by Yaozhong Zhao Breakdown of academic impact, for papers by MR Motta Breakdown of academic impact, for papers by Ryosuke Ogawa Breakdown of academic impact, for papers by Cinnie Yentia Soekojo Breakdown of academic impact, for papers by Gaku Oshikawa
Rankless by CCL
2026